Inc Stemnion Inc

Noveome Biotherapeutics Inc. is a pioneering company based in Pittsburgh, dedicated to advancing innovative therapeutic solutions through its proprietary ST266 biologic. This first-of-its-kind multitargeted secretome contains hundreds of biologically active proteins and factors that play crucial roles in neuroprotection, inflammation modulation, and healing, with significant potential across various medical fields including ophthalmology, neurology, and dermatology.

The company is actively engaged in clinical trials, including a Phase 1/2 trial evaluating ST266 for the treatment of necrotizing enterocolitis in premature infants. Noveome is committed to addressing critical health challenges and improving patient outcomes through its cutting-edge research and development initiatives.

Generated from the website